Bupropion Accord XR 300 mg, Retardtabletten - 90 Swissmedic Key 69559006 Registration Holder Accord Healthcare AG Name Bupropion Accord XR 300 mg, Retardtabletten Date of registration 18.09.2024 Introduction of Sequence 18.09.2024 ATC-Classification Bupropion (N06AX12) Revision date WHO WHO-DDD Valid until 17.09.2029 Index Therapeuticus (BSV) Show package size 90 Index Therapeuticus (Swissmedic) 01.06. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680695590067 Medication Code Synthetika Pharmacode Disponibility
Composition bupropioni hydrochloridum 300 mg, povidonum K 90, cysteini hydrochloridum monohydricum, silica colloidalis anhydrica, glyceroli dibehenas, magnesii stearas, Überzug: ethylcellulosum, povidonum K 90, macrogolum 1450, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas corresp. natrium 0.005 mg, polysorbatum 80, silica colloidalis hydrica, triethylis citras, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, pro compresso obducto. Packungsbestandteile Galenic Form Delayed release tablets Active Agent Dose Bupropion Hydrochloride 300 mg
Inactive agents Dose additional_information Cystein Hydrochloride Monohydrate color. Überzug Drucktinte Macrogol 1450 Polysorbatum 80 90 Propylenglycol Silica Colloidalis Anhydrica
Source Data was imported : 04.10.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
